Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
about
Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS.Autoimmune-like drug-induced liver injury: a review and update for the clinician.Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.The spleen in liver cirrhosis: revisiting an old enemy with novel targets.Biodistribution and function of extracellular miRNA-155 in mice.Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases.Recent advances of exosomes in immune modulation and autoimmune diseases.Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages.Immunomodulatory role of microRNAs transferred by extracellular vesicles.Drug-induced liver injury: Do we know everything?Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.Evidence and potential in vivo functions for biofluid miRNAs: From expression profiling to functional testing: Potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange.From structures to functions: insights into exosomes as promising drug delivery vehicles.Exosomes as Tools to Suppress Primary Brain Tumor.Post isolation modification of exosomes for nanomedicine applications.Emerging role of exosomes in liver physiology and pathology.Functions of Exosomes and Microbial Extracellular Vesicles in Allergy and Contact and Delayed-Type Hypersensitivity.Extracellular vesicles in liver diseases.Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells.Exosomes and their Application in Biomedical Field: Difficulties and Advantages.Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.Isolation of Extracellular Vesicles by Ultracentrifugation.Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7/8 to Polarized Macrophages and Fibrocytes.Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery.Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes.Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo.Emerging applications of exosomes in cancer therapeutics and diagnostics.Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery.Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer.An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles.MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial InfarctionNew Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse Model
P2860
Q27309031-84BE324B-8EA3-45D2-8DDF-8D36AAD88A1EQ30276377-973C55D5-62E9-49ED-AC3B-93780508ABEDQ30277969-BDAC7E4E-2893-4867-A43E-7777400983B9Q30355782-F382C455-4ACA-41B8-870B-A26886F1E769Q30652180-6C8C641C-D818-46D6-B517-D79B69F36C73Q30660817-B9803745-A906-43AC-A95F-D2BE73FA69DCQ35619546-089C405B-F056-4993-B187-A0EAF7539F59Q36040260-91FBA133-A7B8-4434-959C-7CF2BFC49152Q36319389-B4D3BFF9-B1AA-48EF-A242-AA5A631608B1Q36419227-83F2A4B6-D0AB-4F2D-8E39-744D067C58D5Q37229687-24448964-67B5-4405-86C0-40E4D0E65926Q37748005-36EA3363-888D-480C-93A6-BCBEE5ABFC25Q38682574-5CEAF0D7-3BBB-4F82-A2EB-493D9327B12FQ38732775-5C26759D-8BF5-4C99-A461-B71ADA84AB05Q38757881-993AC2EB-37BD-4486-B9EC-52890EFCEC77Q38775093-8CEB1AFA-81E1-4C49-AAE5-3FF131729F7EQ38777386-AD0A89B6-B0CD-41F6-8B19-81C6D9833CE6Q38848034-A12D4641-A5F4-4CFF-8C17-BD17017BD47DQ38931228-5B43EAA9-4AB0-4B44-AB00-C719787169A6Q39002019-461C6D25-96CE-480C-A252-8C9D269C779EQ39063293-66AE6A75-5DA9-4DE1-BE82-AA5CE05E14E3Q39105855-74B4D13F-6C0A-425C-AF67-DB9B973C2B7EQ39301571-CECA4A73-EAD5-4555-A563-450E1F97E0BFQ39387022-DAB15A49-5322-4B7D-9A7F-BD40283C3938Q40084718-BA88B4F7-05B6-48C6-AEB5-1C4CF1672B98Q40358165-38CF0123-0B72-4410-B9E8-1235A38AF701Q40980095-311D3166-E868-4213-AD68-41F0100C9CE6Q41639578-529AE794-DA4B-4704-825C-E5703FC1A5AFQ45862143-54B2C8DF-E4B0-4A47-9594-AD9E26AD213FQ50989161-6413B8F0-F2FF-483D-A3C8-6BEAB146EAC3Q52684454-2D4DF06D-A1B4-4F6C-B18B-5DD6BB013DDCQ52726716-BF149A10-513E-41E4-AB1A-2AB1770AE71EQ54941005-1F9D2899-32AB-488D-B9D8-D17605612FE4Q55004583-CCB4817D-1ECE-4055-9231-72B2EC11013CQ57115991-36C2D502-0672-49E0-B830-AEA2A34752FCQ58756331-AF608EC8-BF5D-4DD2-91CE-FECE0F93EFE0
P2860
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
@en
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
@nl
type
label
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
@en
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
@nl
prefLabel
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
@en
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
@nl
P2093
P2860
P1476
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages
@en
P2093
Gyongyi Szabo
Shashi Bala
Terence Bukong
P2860
P304
P356
10.1016/J.NANO.2014.03.014
P577
2014-03-29T00:00:00Z